Comprehensive analysis of kinase inhibitor selectivity

Area of Science:

• Biochemistry
• Pharmacology
• Genomics

Background:

• The human kinome comprises over 500 kinases, crucial regulators of cellular signaling.
• Kinase inhibitors are vital therapeutic agents, but off-target effects remain a challenge.
• Understanding inhibitor selectivity is key for targeted drug development and basic research.

Purpose of the Study:

• To comprehensively map the interaction landscape between a diverse set of kinase inhibitors and the human kinome.
• To evaluate and compare the selectivity profiles of different classes of kinase inhibitors.
• To identify novel chemical probes for studying kinases lacking specific inhibitors.

Main Methods:

• Screening of 72 kinase inhibitors against 442 human kinases (>80% of the catalytic kinome).
• Quantitative analysis of kinase inhibitor interactions.
• Bioinformatic analysis of interaction patterns to identify selectivity trends.

Main Results:

• Type II kinase inhibitors demonstrated higher selectivity compared to type I inhibitors, with notable exceptions.
• Selective inhibitors are available for most targeted kinases within the tested set.
• A subset of 'group-selective' inhibitors was identified, targeting specific kinase subfamilies.

Conclusions:

• The study provides a valuable resource for selecting appropriate kinase inhibitors as research tools.
• Findings support the development of more selective kinase inhibitors for therapeutic applications.
• The data lay the groundwork for investigating kinase inhibitor-related biology, toxicity, and structural interactions.